Skip to main content
TNET logo

TNET · Trinet Group, Inc.

Track TNET — free
$63.24 -1.62 (-2.50%) At close · Oct 2
Market Cap
$2.99B
Shares
45.90M
Volume · Oct 2 322.24K Avg daily vol (3M) 358.79K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$63.24 Open$65.04 Day$62.26–65.04 52W close$33.85–71.67 Avg vol 30d329K Short int1.8M · 3.9% float · 5.1d Short vol69% Last earningsJul 30, 2026 DataJan 2020–Oct 2026 Filing10-Q · Jul 30

Up next

Next earnings call
Nov 1, 2026 Est · unconfirmed · in 4 wks
filed Jul 30, 2026
call held Jul 30, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$4.88B
Trailing 12 months
Net income (TTM)
$175.00M
Trailing 12 months
Revenue growth YoY
-4.8%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
16.8
Trailing earnings · reciprocal yield 6.0%
FCF yield
9.6%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-6.1%
Year over year · fewer shares
Price change (1Y)
-1.6%
Trailing year
Short interest
3.9%
Latest settlement · 5.1 days to cover
View all 115 metrics

AI Brief

Q2 FY26 earnings call · Jul 30, 2026
Q2 FY26

TL;DR. TriNet raised full-year earnings guidance, posting Q2 adjusted EPS of $1.55 (up 35% YoY) on better-than-expected insurance results, improved retention, and disciplined costs, while total revenues declined 5% and average WSEs fell 11% YoY.

Bullish
  • + Raised full-year 2026 adjusted EPS guidance range to $4.50–$5.10 and adjusted EBITDA margin to 8.5%–9.0%
  • + Q2 adjusted EPS grew 35% YoY to $1.55 and GAAP EPS grew 50% to $1.15
  • + Insurance cost ratio improved 4 points YoY to 86% with stable high-single-digit health cost trends
  • + Broker channel represented 32% of new sales with RFPs up 54% YoY; senior sales reps productivity up 13% YoY
  • + Free cash flow grew 18% YoY to $67 million in Q2 on disciplined expense management and better insurance performance
Bearish
  • − Total revenues declined 5% YoY to $1.2 billion driven by lower WSE volumes from prior repricing actions
  • − Average WSEs declined 11% YoY to approximately 298,000 and co-employed WSEs fell 11% to ~274,000
  • − Professional service revenue declined 8% YoY to $159 million impacted by lower co-employed WSEs
  • − Q2 sales ended flat YoY after challenges in March/April, though sales force was contracted in 2H25/1H26
  • − Interest revenue declined 33% YoY to $12 million due to expected reduction of cash balances for certain tax credits

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Strong Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +20%
above
Price vs 50-day avg −6%
below
RSI (14) 41
neutral
MACD trend Negative
52-week position 78%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return −9%
trailing
6-month return +70%
trailing
YTD return +7%
this year
Relative strength +57%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $68 › 200d $53 — 50d above 200d
Institutional flow Flat
1 of 280 funds reported for Sep 30 · net 0 sh shares
Insider flow Distributing
Net -$563.9K over 90 days · 100% sells
Short interest Rising
3.90% of float · ▲ +14.2% MoM · 5.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
280 holders — near 3-yr high, broad support
Squeeze score 69
elevated · 0–100
Fundamentals
Strong
Revenue growth −1%
Y/Y
EPS growth −7%
Y/Y
Free cash flow $234.0M
Valuation P/E 17.1
below peers
Buyback $329.0M
remaining
Quant / Vol
risk profile
Very High
Volatility 48%
annualized · 1-yr
Max drawdown −49%
past year
ATR 3.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 6 of last 8
Latest guidance · from the 8-K filed Jul 30, 2026
Diluted net income per share of common stock · Full Year 2026 Initiated $2.85 – $3.35
prior FY $3.20 midpoint −3.1% Y/Y
Adjusted Net Income per share - diluted · Full Year 2026 Initiated $4.50 – $5.10
Guided vs delivered · last 8 settled
Diluted net income per share of common stock Full Year 2024
guided $3.94 – $5.46
$3.43 Miss −27.0%
Diluted net income per share of common stock Q2 2024
guided $0.68 – $1.17
$1.20 Beat +29.7%
Diluted net income per share of common stock Q1 2024
guided $1.82 – $2.54
$1.78 Miss −18.3%
Diluted net income per share of common stock Full Year 2023
guided $5.43 – $6.27
$6.56 Beat +12.1%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+20% Bullish
Price vs 50-day avg
−6% Bearish
RSI (14)
41 Neutral
MACD trend
Negative Bearish
52-week position
78% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $68 › 200d $53 — 50d above 200d
Institutional flow Flat
1 of 280 funds reported for Sep 30 · net 0 sh shares
Insider flow Distributing
Net -$563.9K over 90 days · 100% sells
Short interest Rising
3.90% of float · ▲ +14.2% MoM · 5.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
280 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $34 Now $63 · 78% Range high $72
vs 200-day avg +20% vs 50-day avg -6%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Staffing & Employment Services — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
TNET
Trinet Group, Inc.
this stock
$2.99B +7.0% -0.9% 17.1 3.9%
KFY
Korn Ferry
$3.91B +8.9% +12.2% 13.6 4.0%
RHI
Robert Half Inc.
$3.78B +33.0% -7.2% 32.1 19.2%
MAN
ManpowerGroup Inc.
$2.67B +82.2% +0.6% 26.0 9.7%
NSP
Insperity, Inc.
$1.83B +20.0% +3.5% — 7.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders
Holders
280
% held
96.0%
Reported
1 of 280
Top holder
Atairos Group, Inc.
Held Float
View
Held by Funds
Fund positions
237
View
Short & Settlement
Short Interest Rising
Shares short
1.8M
Days to cover
5.1d
Change
+223.1K sh
View
Short Volume
Short vol %
69%
As of
Oct 2, 2026
Short Total
View
Fails to Deliver
FTD shares
299
Value
$19.7K
As of
Sep 14, 2026
View
Off-Exchange
Off-exchange %
40.7%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$563.9K
Buyers / Sellers
0 / 2
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$5.0B
Net income (FY)
$155.0M
EPS diluted
$3.20
View
Buybacks
Authorized
$3.1B
Remaining
$329.0M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 14, 2026
This year
12
View
Proposed Sales
Value
$167.3K
Shares
2.4K
Filed
Aug 27, 2026
View
Exempt Offerings
Offering
$16.7M
Filed
Mar 1, 2022
View
Earnings & Events
Webcasts
Last webcast
Jul 30, 2026
View
Investor Relations
Latest news
TriNet Launches 'What You Really…
Published
Sep 28, 2026
View

Performance

5D 20D 120D MTD YTD
TNET -2.9% -8.9% +69.5% +1.1% +7.0%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY -2.7% -8.4% +57.3% +0.2% -5.9%

Capital returns

Buyback program · as of Jun 30, 2026
Authorized
$3.05B
Spent (derived)
$2.72B
Remaining
$329.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 937098 CUSIP 896288107 13F (30d) 5 filings 5 filers Visit website Investor relations